Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT - ASSETS

3 Months Ended

Mar. 31, 2024

NOTE 4 — SELECTED FINANCIAL STATEMENT — ASSETS

Inventories consisted of the following (in thousands):


	March 31, 2024			December 31, 2023
Raw materials and components	$	1,313		$	1,329
Work-in-process		200			186
Finished goods		4,993			5,163
Inventory reserve		(4,979	)		(4,967	)
Total inventories, net	$	1,527		$	1,711

Prepaid expenses and other current assets consisted of the following (in thousands):


	March 31, 2024		December 31, 2023
Prepaid insurance	$	411	$	595
Prepaid expenses		442		536
Other current assets		762		596
Total prepaid expenses and other current assets	$	1,615	$	1,727

Property and equipment consisted of the following (in thousands):


	March 31, 2024			December 31, 2023
Equipment	$	384		$	383
Leasehold improvements		39			39
Furniture and fixtures		99			99
Total property and equipment		522			521
Less: accumulated depreciation		(465	)		(462	)
Total property and equipment, net	$	57		$	59

During the three months ended March 31, 2024 and 2023, depreciation expense was approximately $6,000 and $9,000, respectively.